# Nipro Renal Solutions USA, Corp.

- Location (FDA's records): Lewisberry, PA
- FDA decisions: 2 (2020–2023): 2 510(k) clearances
- Product codes: KPO (2)
- Predicates its devices cite: 7 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Diasol, Inc.: 2 (https://510kreport.com/company/diasol)
- Granite Chemical Co., Inc.: 2 (https://510kreport.com/company/granite-chemical)
- Rockwell Medical: 1 (https://510kreport.com/company/rockwell-medical)
- Dimesol USA, LLC: 1 (https://510kreport.com/company/dimesol-usa)
- Dialysis Medical Solutions, LLC: 1 (https://510kreport.com/company/dialysis-medical-solutions)

## Firms that cite its devices most
- Nipro Technical Solutions, Incoporated: 1 (https://510kreport.com/company/nipro-technical-solutions-incoporated)

## Its most-cited devices
- K223431: Citric Complete Liquid Citric Acid Concentrate (2023), cited by 1

## Recent decisions
- K223431: Citric Complete Liquid Citric Acid Concentrate (Aug 4, 2023)
- K193155: Nipro Dry Complete Dry Acid Concentrate for Hemodialysis (Nov 25, 2020)

Source page: https://510kreport.com/company/nipro-renal-solutions-usa